NEUROMYELITIS OPTICA

Clinical trials for NEUROMYELITIS OPTICA explained in plain language.

Never miss a new study

Get alerted when new NEUROMYELITIS OPTICA trials appear

Sign up with your email to follow new studies for NEUROMYELITIS OPTICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

New attack on rare nerve disease aims to cut harmful steroids

Disease control Not yet recruiting

This study is testing a drug called inectolizumab for people newly diagnosed with a rare autoimmune disease that attacks the nerves and spinal cord (NMOSD). The main goal is to see if the drug can help control the disease while allowing patients to take fewer steroids, which have…

Matched conditions: NEUROMYELITIS OPTICA

Phase: NA • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

NEUROMYELITIS OPTICA

Get alerted when new NEUROMYELITIS OPTICA trials appear

New attack on rare nerve disease aims to cut harmful steroids